The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03117036
Recruitment Status : Recruiting
First Posted : April 17, 2017
Last Update Posted : November 27, 2023
Sponsor:
Collaborator:
Samsung Genomic Institute
Information provided by (Responsible Party):
Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 28, 2024
Estimated Study Completion Date : December 28, 2026